These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 23113585)

  • 1. Computational Method for Quantitative Comparison of Activity Landscapes on the Basis of Image Data.
    Iqbal J; Vogt M; Bajorath J
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32872506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crowdsourced mapping of unexplored target space of kinase inhibitors.
    Cichońska A; Ravikumar B; Allaway RJ; Wan F; Park S; Isayev O; Li S; Mason M; Lamb A; Tanoli Z; Jeon M; Kim S; Popova M; Capuzzi S; Zeng J; Dang K; Koytiger G; Kang J; Wells CI; Willson TM; ; Oprea TI; Schlessinger A; Drewry DH; Stolovitzky G; Wennerberg K; Guinney J; Aittokallio T
    Nat Commun; 2021 Jun; 12(1):3307. PubMed ID: 34083538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional probabilistic analysis for prediction of the activity landscape and relative compound activities.
    Santos RG; Giulianotti MA; Houghten RA; Medina-Franco JL
    J Chem Inf Model; 2013 Oct; 53(10):2613-25. PubMed ID: 23971977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring chemical space, scaffold diversity, and activity landscape of spleen tyrosine kinase active inhibitors.
    Danishuddin ; Malik MZ; Kashif M; Haque S; Kim JJ
    SAR QSAR Environ Res; 2024 Apr; 35(4):325-342. PubMed ID: 38690773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Comparison of Three-Dimensional Activity Landscapes of Compound Data Sets Based upon Topological Features.
    Iqbal J; Vogt M; Bajorath J
    ACS Omega; 2020 Sep; 5(37):24111-24117. PubMed ID: 32984733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finding Constellations in Chemical Space Through Core Analysis.
    Naveja JJ; Medina-Franco JL
    Front Chem; 2019; 7():510. PubMed ID: 31380353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mining Patents with Large Language Models Elucidates the Chemical Function Landscape.
    Kosonocky CW; Wilke CO; Marcotte EM; Ellington AD
    ArXiv; 2023 Dec; ():. PubMed ID: 38196747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promiscuous Ligands from Experimentally Determined Structures, Binding Conformations, and Protein Family-Dependent Interaction Hotspots.
    Gilberg E; Gütschow M; Bajorath J
    ACS Omega; 2019 Jan; 4(1):1729-1737. PubMed ID: 31459430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based chemogenomics: analysis of protein family landscapes.
    Pirard B
    Methods Mol Biol; 2009; 575():281-96. PubMed ID: 19727620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of activity landscapes for drug discovery.
    Bajorath J
    Expert Opin Drug Discov; 2012 Jun; 7(6):463-73. PubMed ID: 22475223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a three-dimensional multitarget activity landscape.
    de la Vega de León A; Bajorath J
    J Chem Inf Model; 2012 Nov; 52(11):2876-83. PubMed ID: 23113585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of multitarget activity landscapes that capture hierarchical activity cliff distributions.
    Dimova D; Wawer M; Wassermann AM; Bajorath J
    J Chem Inf Model; 2011 Feb; 51(2):258-66. PubMed ID: 21275393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of multitarget activity ridges in high-dimensional bioactivity spaces.
    Gupta-Ostermann D; Bajorath J
    J Chem Inf Model; 2012 Oct; 52(10):2579-86. PubMed ID: 23004919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactivity landscape modeling: chemoinformatic characterization of structure-activity relationships of compounds tested across multiple targets.
    Waddell J; Medina-Franco JL
    Bioorg Med Chem; 2012 Sep; 20(18):5443-52. PubMed ID: 22178187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Navigating high-dimensional activity landscapes: design and application of the ligand-target differentiation map.
    Iyer P; Dimova D; Vogt M; Bajorath J
    J Chem Inf Model; 2012 Aug; 52(8):1962-9. PubMed ID: 22794307
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.